Cobalt/iron bimetallic oxide coated with graphitized nitrogen-doped carbon (FeO-CoO@NC) derived from cobalt/iron solid complex as peroxymonosulfate (PMS) activator for efficient bensulfuron-methyl degradation.

Cobalt/iron bimetallic oxide coated with graphitized nitrogen-doped carbon (FeO-CoO@NC) was synthesized by convenient solid phase coordination combined with calcination method to activate PMS for the degradation of BSM. A series of Co/Fe bimetallic oxides with different metal ratios were designed and prepared to select the most efficient catalyst and FeO-CoO@NC(Co:Fe = 1:1) demonstrated the highest catalytic activity and the lowest ions leaching. The reasons for high catalytic activity of FeO-CoO@NC(Co:Fe = 1:1) were evaluated by a range of characterization techniques and the results showed it stemmed from higher mental content and larger current density.

3D magnetic flower-spherical FeO-NiO derived from NiFe-layered double hydroxides for the efficient removal of Bensulfuron methyl: Morphological control and bimetallic synergy.

Three-dimensional (3D) magnetic flower-spherical FeO-NiO derived from NiFe-layered double hydroxides (NiFe-LDHs) was fabricated through urea hydrothermal and calcination methods. The as-prepared materials were applied to activate PMS to degrade one of herbicide named Bensulfuron methyl (BSM). FeO-NiO-1 demonstrated the highest catalytic activity and the lowest ions leaching by comparing the performance of LDHs and derivative bimetallic oxide synthesized by co-precipitation method, urea hydrothermal method and direct calcination method.

Eight-month intensive meditation-based intervention improves refractory hallucinations and delusions and quality of life in male inpatients with schizophrenia: a randomized controlled trial.

Aim: This study investigated the impact of an 8-month daily-guided intensive meditation-based intervention (iMI) on persistent hallucinations/delusions and health-related quality of life (QoL) in male inpatients with schizophrenia with treatment-refractory hallucinations and delusions (TRHDs).

Methods: A randomized controlled trial assigned 64 male inpatients with schizophrenia and TRHD equally to an 8-month iMI plus general rehabilitation program (GRP) or GRP alone. Assessments were conducted at baseline and the third and eighth months using the Positive and Negative Syndrome Scale (PANSS), 36-Item Short Form-36 (SF-36), and Five Facet Mindfulness Questionnaire (FFMQ).

Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort.

Background: Antipsychotics are known to be associated with metabolic syndromes (MetS). Chlorpromazine (CPZ) and Clozapine (CLZ) are currently the most commonly used antipsychotics in low-income districts of China. However, potential differences in the long-term effects of CPZ and CLZ on MetS in schizophrenia inpatients are not well understood.

Three-dimensional flower-like magnetic CoFe-LDHs/CoFeO composites activating peroxymonosulfate for high efficient degradation of aniline.

In this study, 3D flower-like magnetic CoFe-LDHs/CoFeO was prepared by a facile urea hydrothermal method and utilized to activate peroxymonosulfate (PMS) for degrading aniline (AN). CoFe-LDHs/CoFeO was systematically characterized to explore the relationship between its structure and catalytic performance. Compared with CoFe-LDHs synthesized by co-precipitation method, CoFe-LDHs/CoFeO exhibited three dimensional structure and larger specific surface, which could increase the degradation efficiency of AN markedly.

Evaluation of paliperidone on social function in patients with chronic schizophrenia.

Background: The impairment of social function is widespread in the patients with chronic schizophrenia, which seriously affects family, life and work conditions.

Aims: The main purpose of this study was to investigate the efficacy of paliperidone in the treatment of social function in chronic schizophrenia.

Methods: A total of 81 patients who met the standard criteria for schizophrenia and long-term hospitalised inpatients were randomly divided into the treatment group and normal control group following a 1- year prospective follow-up study.